ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,367
Screening encounters
3,897
Diagnostic referrals
744
Outstanding pathways
280

Screening pathway

  1. Screening3,897Encounters
  2. Positive finding1,352Documented findings
  3. Referral744Diagnostic referrals
  4. Follow-up872Diagnostic visits
  5. Outcome464Resolved pathways

Stage totals use different units. Pending pathways: 280. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4341 · EXP-4341Synthetic · Site D

Full participant history through 2026-08-24, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA technically uninterpretable · Inadequate
  3. · Repeat plan · VIA · Inadequate result · Scheduled for 2025-05-08
  4. · Screening · VIA · Repeat · Inadequate result
  5. · Screening result · VIA · VIA positive · Adequate
  6. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-01-18
  7. · Diagnostic referral · EXP-4341-T-R
  8. · Contact attempt · Reached
  9. · Diagnostic booking · Initial booking
  10. · Diagnostic visit · Missed
  11. · Diagnostic booking · Rebooking
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-10-18
  16. · Follow-up disposition · Resolved · EXP-4341-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3367 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4014 · Expanded synthetic participant 4014Site E — Resource-Constrained Navigation Programme
EXP-4015 · Expanded synthetic participant 4015Site E — Resource-Constrained Navigation Programme
EXP-4017 · Expanded synthetic participant 4017Site D — Community Engagement Programme
EXP-4019 · Expanded synthetic participant 4019Site A — Urban Referral Hub
EXP-4021 · Expanded synthetic participant 4021Site E — Resource-Constrained Navigation Programme
EXP-4022 · Expanded synthetic participant 4022Site C — Rural Outreach Programme
EXP-4023 · Expanded synthetic participant 4023Site D — Community Engagement Programme
EXP-4025 · Expanded synthetic participant 4025Site E — Resource-Constrained Navigation Programme
EXP-4027 · Expanded synthetic participant 4027Site A — Urban Referral Hub
EXP-4028 · Expanded synthetic participant 4028Site C — Rural Outreach Programme
EXP-4029 · Expanded synthetic participant 4029Site B — Peri-Urban Access Programme
EXP-4030 · Expanded synthetic participant 4030Site E — Resource-Constrained Navigation Programme
EXP-4031 · Expanded synthetic participant 4031Site C — Rural Outreach Programme
EXP-4033 · Expanded synthetic participant 4033Site D — Community Engagement Programme
EXP-4034 · Expanded synthetic participant 4034Site A — Urban Referral Hub
EXP-4035 · Expanded synthetic participant 4035Site B — Peri-Urban Access Programme
EXP-4038 · Expanded synthetic participant 4038Site D — Community Engagement Programme
EXP-4039 · Expanded synthetic participant 4039Site D — Community Engagement Programme
EXP-4040 · Expanded synthetic participant 4040Site B — Peri-Urban Access Programme
EXP-4041 · Expanded synthetic participant 4041Site B — Peri-Urban Access Programme
EXP-4042 · Expanded synthetic participant 4042Site B — Peri-Urban Access Programme
EXP-4043 · Expanded synthetic participant 4043Site B — Peri-Urban Access Programme
EXP-4045 · Expanded synthetic participant 4045Site A — Urban Referral Hub
EXP-4046 · Expanded synthetic participant 4046Site A — Urban Referral Hub
EXP-4049 · Expanded synthetic participant 4049Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1540
HPV DNA
1801
Cytology
556

Navigation activity

Barrier documented
641
Contact attempt
1089
Navigation intervention
274
Diagnostic booking
916
Diagnostic visit
872

Documented barriers

Contact difficulty
213
Transport difficulty
201
Appointment coordination
227

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.